Tag : HCC

AASLD/IDSA recently published evidence-based practice recommendations, drawing on growing evidence of CHB prevention, surveillance, and treatment, to provide clear, practical guidance for health care professionals in optimizing care for individuals with CHB.

MASLD drives persistent HCC risk despite HCV cure: Insights from a Japanese multicenter cohort study

The prospective ALTUS study found that a multi-target HCC blood test (mt-HBT) outperformed ultrasound in detecting early- and very early-stage hepatocellular carcinoma (HCC). By providing operator-independent and scalable surveillance, mt-HBT offers a promising alternative to imaging, with the potential to enhance early detection, adherence, and clinical outcomes in at-risk patients.